Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Sexually Transmitted Diseases

  Free Subscription


Articles published in Int J Gynaecol Obstet

Retrieve available abstracts of 42 articles:
HTML format
Text format



Single Articles


    September 2018
  1. MARSHALL C, Chavan B, Haile ZT
    The moderating role of race/ethnicity on associations between insurance status and HPV vaccination among women in the USA.
    Int J Gynaecol Obstet. 2018 Sep 21. doi: 10.1002/ijgo.12683.
    PubMed     Text format     Abstract available


    August 2018
  2. OBERLIN AM, Rahangdale L, Chinula L, Fuseini NM, et al
    Making HPV vaccination available to girls everywhere.
    Int J Gynaecol Obstet. 2018 Aug 24. doi: 10.1002/ijgo.12656.
    PubMed     Text format     Abstract available


  3. YALCIN I, Sari ME, Sahin H, Gultekin M, et al
    Colposcopic biopsy findings among women with either HPV-16 only or HPV-18 only who have normal cervical cytology.
    Int J Gynaecol Obstet. 2018 Aug 20. doi: 10.1002/ijgo.12652.
    PubMed     Text format     Abstract available


    July 2018
  4. SENKOMAGO V, Ting J, Kwatampora J, Gukare H, et al
    High-risk HPV-RNA screening of physician- and self-collected specimens for detection of cervical lesions among female sex workers in Nairobi, Kenya.
    Int J Gynaecol Obstet. 2018 Jul 26. doi: 10.1002/ijgo.12628.
    PubMed     Text format     Abstract available


  5. ROURA-MONLLOR J, Nieves-Munoz J, Ortiz AP, Romaguera J, et al
    HPV knowledge, vaccine knowledge, and vaccine acceptance in women with cervical cytology anomalies attending colposcopy clinics in Puerto Rico.
    Int J Gynaecol Obstet. 2018 Jul 10. doi: 10.1002/ijgo.12594.
    PubMed     Text format     Abstract available


  6. MANAMELA PK, Kgomo KA, van Gelderen CJ, Lekha AR, et al
    Low-grade squamous intraepithelial lesions among women with HIV.
    Int J Gynaecol Obstet. 2018;142:78-83.
    PubMed     Text format     Abstract available


    June 2018
  7. ROBLES C, Wiesner C, Martinez S, Salgado Y, et al
    Impact of operational factors on HPV positivity rates in an HPV-based screening study in Colombia.
    Int J Gynaecol Obstet. 2018 Jun 26. doi: 10.1002/ijgo.12574.
    PubMed     Text format     Abstract available


  8. BOGANI G, Taverna F, Lombardo C, Signorelli M, et al
    Potential impact of introducing a nonavalent HPV vaccination.
    Int J Gynaecol Obstet. 2018 Jun 2. doi: 10.1002/ijgo.12546.
    PubMed     Text format     Abstract available


  9. BERGENGREN L, Kaliff M, L Larsson G, Karlsson MG, et al
    Comparison between professional sampling and self-sampling for HPV-based cervical cancer screening among postmenopausal women.
    Int J Gynaecol Obstet. 2018 Jun 1. doi: 10.1002/ijgo.12538.
    PubMed     Text format     Abstract available


  10. JUNTASOPEEPUN P, Thana K
    Parental acceptance of HPV vaccines in Chiang Mai, Thailand.
    Int J Gynaecol Obstet. 2018 Jun 1. doi: 10.1002/ijgo.12539.
    PubMed     Text format     Abstract available


    February 2018
  11. HERACLIO SA, de Souza ASR, de Souza PRE, Katz L, et al
    Cross-sectional study of anal intraepithelial lesions in women with cervical neoplasia without HIV.
    Int J Gynaecol Obstet. 2018;140:233-240.
    PubMed     Text format     Abstract available


    January 2018
  12. MAGED AM, Saad H, Salah E, Meshaal H, et al
    Urine test for HPV genotypes as a predictor of precancerous cervical lesions and for cervical cancer screening.
    Int J Gynaecol Obstet. 2018 Jan 31. doi: 10.1002/ijgo.12453.
    PubMed     Text format     Abstract available


    December 2017
  13. RIZZUTO I, Nalam M, Jiang J, Linder A, et al
    Risk factors for HPV persistence and cytology anomalies at follow-up after treatment for cervical dysplasia.
    Int J Gynaecol Obstet. 2017 Dec 17. doi: 10.1002/ijgo.12431.
    PubMed     Text format     Abstract available


  14. HUCHKO MJ, Ibrahim S, Blat C, Cohen CR, et al
    Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya.
    Int J Gynaecol Obstet. 2017 Dec 2. doi: 10.1002/ijgo.12415.
    PubMed     Text format     Abstract available


    October 2017
  15. EBENEZER ED, Benjamin SJ, Sahni RD, Prakash JA, et al
    A retrospective study of the prevalence and outcomes of syphilis in pregnancy in a five-year period.
    Int J Gynaecol Obstet. 2017 Oct 5. doi: 10.1002/ijgo.12336.
    PubMed     Text format     Abstract available


    July 2017
  16. LAMONTAGNE DS, Bloem PJN, Brotherton JML, Gallagher KE, et al
    Progress in HPV vaccination in low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:7-14.
    PubMed     Text format     Abstract available


  17. OGILVIE G, Nakisige C, Huh WK, Mehrotra R, et al
    Optimizing secondary prevention of cervical cancer: Recent advances and future challenges.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:15-19.
    PubMed     Text format     Abstract available


  18. BASU P, Meheus F, Chami Y, Hariprasad R, et al
    Management algorithms for cervical cancer screening and precancer treatment for resource-limited settings.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:26-32.
    PubMed     Text format     Abstract available


  19. CAMPOS NG, Sharma M, Clark A, Lee K, et al
    The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:47-56.
    PubMed     Text format     Abstract available


  20. WITTET S, Aylward J, Cowal S, Drope J, et al
    Advocacy, communication, and partnerships: Mobilizing for effective, widespread cervical cancer prevention.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:57-62.
    PubMed     Text format     Abstract available


  21. HOLME F, Kapambwe S, Nessa A, Basu P, et al
    Scaling up proven innovative cervical cancer screening strategies: Challenges and opportunities in implementation at the population level in low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:63-68.
    PubMed     Text format     Abstract available


  22. DRUMMOND JL, Were MC, Arrossi S, Wools-Kaloustian K, et al
    Cervical cancer data and data systems in limited-resource settings: Challenges and opportunities.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:33-40.
    PubMed     Text format     Abstract available


  23. TSU VD, Ginsburg O
    The investment case for cervical cancer elimination.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:69-73.
    PubMed     Text format     Abstract available


  24. ARANDA S, Berkley S, Cowal S, Dybul M, et al
    Ending cervical cancer: A call to action.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:4-6.
    PubMed     Text format     Abstract available


  25. TSU VD
    Cervical cancer prevention for all women: Why now?
    Int J Gynaecol Obstet. 2017;138 Suppl 1:1-3.
    PubMed     Text format    


    June 2017
  26. PISTA A, de Oliveira CF, Lopes C, Cunha MJ, et al
    Potential impact of nonavalent HPV vaccine in the prevention of high-grade cervical lesions and cervical cancer in Portugal.
    Int J Gynaecol Obstet. 2017 Jun 20. doi: 10.1002/ijgo.12243.
    PubMed     Text format     Abstract available


  27. LASKOW B, Figueroa R, Alfaro KM, Scarinci IC, et al
    A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador.
    Int J Gynaecol Obstet. 2017 Jun 7. doi: 10.1002/ijgo.12204.
    PubMed     Text format     Abstract available


  28. CHIGBU CO, Onyebuchi AK, Onyeka TC, Odugu BU, et al
    The impact of community health educators on uptake of cervical and breast cancer prevention services in Nigeria.
    Int J Gynaecol Obstet. 2017;137:319-324.
    PubMed     Text format     Abstract available


    May 2017
  29. LI Y, Rong S, Zhi Y, Qiu C, et al
    Detection of cervical intraepithelial neoplasia with HPVE6/E7 mRNA among women with atypical squamous cells of unknown significance.
    Int J Gynaecol Obstet. 2017;137:145-149.
    PubMed     Text format     Abstract available


    April 2017
  30. BOGANI G, Taverna F, Lombardo C, Borghi C, et al
    Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology.
    Int J Gynaecol Obstet. 2017 Apr 7. doi: 10.1002/ijgo.12170.
    PubMed     Text format     Abstract available


    February 2017
  31. TAY SK, Hsu TY, Shcheprov A, Walia A, et al
    The clinical and economic benefits of school-based quadrivalent HPV vaccination in Singapore.
    Int J Gynaecol Obstet. 2017 Feb 11. doi: 10.1002/ijgo.12126.
    PubMed     Text format     Abstract available


  32. PATEL H, Pcolkina K, Strazdina K, Viberga I, et al
    Awareness of HPV infection and attitudes toward HPV vaccination among Latvian adolescents.
    Int J Gynaecol Obstet. 2017 Feb 7. doi: 10.1002/ijgo.12117.
    PubMed     Text format     Abstract available


  33. GONZALEZ-BOSQUET E, Fernandez S, Sabra S, Lailla JM, et al
    Negative HPV testing among patients with biopsy-proven cervical intraepithelial neoplasia grade 2/3 or cervical cancer.
    Int J Gynaecol Obstet. 2017;136:229-231.
    PubMed     Text format     Abstract available


    January 2017
  34. GIANNELLA L, Fodero C, Boselli F, Rubino T, et al
    Age-related changes in pre- and post-conization HPV genotype distribution among women with high-grade cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2017 Jan 27. doi: 10.1002/ijgo.12106.
    PubMed     Text format     Abstract available


  35. FIGUEROA-DOWNING D, Baggio ML, Baker ML, Dias De Oliveira Chiang E, et al
    Factors influencing HPV vaccine delivery by healthcare professionals at public health posts in Sao Paulo, Brazil.
    Int J Gynaecol Obstet. 2017;136:33-39.
    PubMed     Text format     Abstract available


  36. ZHANG G, Lang J, Shen K, Zhu L, et al
    High-risk human papillomavirus infection clearance following conization among patients with cervical intraepithelial neoplasm grade 3 aged at least 45 years.
    Int J Gynaecol Obstet. 2017;136:47-52.
    PubMed     Text format     Abstract available


  37. FAJARDO-RAMIREZ OR, Barboza-Cerda MC, Ortiz-Lopez R, Rojas-Martinez A, et al
    Prevalence and 3-year persistence of human papillomavirus serotypes in asymptomatic patients in Northern Mexico.
    Int J Gynaecol Obstet. 2017;136:40-46.
    PubMed     Text format     Abstract available


    December 2016
  38. MARIANI L, Preti M, Cristoforoni P, Stigliano CM, et al
    Overview of the benefits and potential issues of the nonavalent HPV vaccine.
    Int J Gynaecol Obstet. 2016 Dec 7. doi: 10.1002/ijgo.12075.
    PubMed     Text format     Abstract available


    November 2016
  39. MARIANI L, Igidbashian S, Sandri MT, Vici P, et al
    The clinical implementation of primary HPV screening.
    Int J Gynaecol Obstet. 2016 Nov 21. doi: 10.1002/ijgo.12065.
    PubMed     Text format     Abstract available


    July 2016
  40. OLALEYE O, Olamijulo JA
    The value of chlamydial antibody level for predicting tubal blockage among women undergoing hysterosalpingography in Lagos, Nigeria.
    Int J Gynaecol Obstet. 2016;134:33-6.
    PubMed     Text format     Abstract available


    April 2016
  41. ZHANG J, Chang X, Qi Y, Zhang Y, et al
    A retrospective study of 152 women with vaginal intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2016;133:80-3.
    PubMed     Text format     Abstract available


    January 2016
  42. KOO YJ, Kim YS, Min KJ, Hong JH, et al
    High-risk human papillomavirus infection in the prediction of poor treatment response and disease recurrence in patients with vulvovaginal condyloma.
    Int J Gynaecol Obstet. 2016;132:20-4.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: